Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Business & Regulation Trends & Forecasts

Mergers and Big Decisions

| George Chressanthis, Randy Risser

The CVS-Aetna merger could be a transformative event for the pharmaceutical industry. Shrewd negotiating decisions, analytics and real world evidence have never been more important.

Business & Regulation Business Practice

Facing the Brexit Trial

| James Strachan

A “no-deal” Brexit poses unique challenges for the drug development and advanced therapy sectors – not least tight timelines and a limited ability to stockpile. Here, we explore the potential pain points and find out what companies can do to prepare.

Discovery & Development Formulation

Taking a Byte out of Formulation Development

| Ronak Savla, Julien Meissonnier, Jan Neelissen

With so much technology at our disposal, it’s time to get smart in formulation by adopting in silico approaches.

Register to personalize your newsfeed

Create Account

Latest Articles

Manufacture Contract Manufacturing Services

Phasing Out Inefficiency

| Simon Tyler

Struggling with process research and development? Find yourself a CRO that knows what it’s doing.

Discovery & Development Drug Delivery

The Elderly Are the Future

| Erin O’Brien, Chris Evans

Drug delivery devices must take into account the needs of older adults.

Discovery & Development Formulation

In Conversation with Dr. Martin Klatt of BASF

The Medicine Maker speaks with Dr. Martin Klatt, Director Sales Pharma Solutions Europe from BASF

Discovery & Development Formulation

Taste the Rainbow

| Nicolas Medit

The color of a capsule or tablet can have a big impact on compliance and branding. To avoid delays, early decisions have to be made.

Discovery & Development Small Molecules

Solutions in... Drug Development

| James Strachan

Douglas J. Swirsky, CEO of Rexahn Pharmaceuticals, explains his company’s approach to developing more effective cancer treatments.

Manufacture Technology and Equipment

Who's the Best?

| Stephanie Sutton

Vote now for the top drug development technology of 2018.

Discovery & Development Formulation

In Conversation with Jeanne Thoma of SPI Pharma

| James Strachan

The Medicine Maker speaks with Jeanne Thoma, President and CEO from SPI Pharma

Discovery & Development Formulation

Owner of a Lonely Heart

| Jessica Finlay

In 2018, the UK’s government appointed its first Minister for Loneliness. The role: to tackle loneliness.

Discovery & Development Ingredients

In Conversation with Christophe Le Ret of Umicore

| James Strachan

The Medicine Maker speaks with Christophe Le Ret, Global Marketing Director of Umicore

Discovery & Development Drug Discovery

The (Secret) Barrier Breaker

| Maryam Mahdi

Sitting Down With… Steve Arlington, President at the Pistoia Alliance.

All Articles

Upcoming Events

-

AsiaTIDES: Oligonucleotide and Peptide Therapeutics

Tokyo, Japan

AsiaTIDES is the only event in Asia that brings together the science, technologies and partners you need to accelerate...

-

Eye for Pharma

Barcelona, Spain

1300+ pharma decision makers come together at eyefopharma Barcelona 2019. The most significant global meeting for...

-

DCAT

New York, USA

CAT Week ‘19: Business Development | Networking | Industry Education
DCAT Week is the premier business development...

All Events

Sister Publications

You might be interested in our Sister Publications:


Latest White Papers

Technology for combating counterfeit medicine

| Contributed by Malvern Panalytical

All White Papers

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register